• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic logs wins in overcharging lawsuit, defibrillator case fees

Medtronic logs wins in overcharging lawsuit, defibrillator case fees

January 17, 2018 By Sarah Faulkner

gavelMedtronic (NYSE:MDT) logged a series of legal wins this week after a federal judge dismissed a whistleblower lawsuit against the medtech titan and the U.S. Supreme Court declined to review a bid over legal fees in a long-running patent spat, upholding Medtronic’s victory from April last year.

In a lawsuit brought against Medtronic, Cavallino Consulting alleged that the medtech company defrauded government hospitals by overcharging them for the speedy delivery of medical equipment, without passing along required discounts.

U.S. district judge David Doty of Minneapolis ruled that the argument brought by Cavallino Consulting did not credibly allege that Medtronic engaged in “a broad and ongoing scheme to defraud,” and the judge pointed out that the complaint didn’t plausibly allege that Medtronic submitted any claims to the government, let alone fraudulent claims.

Doty added that Cavallino Consulting did not explain how it could claim that Medtronic was receiving discounts from carriers, considering it audits hospitals and not medical device-makers.

“Whether and to what extent Medtronic may receive carrier discounts is pure speculation,” Doty wrote.

Even if Medtronic arranged sales with government hospitals and failed to pass along the carrier discounts, the judge noted that is debatable whether that would violate the contract presented to the court.

“Although relator’s interpretation of the expedited delivery provision is not unreasonable, the provision does not clearly require Medtronic to charge government hospitals for expedited shipping costs actually incurred. Absent such clarity, Medtronic could not have ‘knowingly’ submitted a false claim to the government as that term is defined under the FCA,” Doty wrote.

Also this week, the Supreme Court declined to consider a bid by the family of defibrillator pioneer Dr. Michel Mirowski to win legal fees in a long-standing patent royalties spat.

In April last year, a federal appeals court ruled that Mirowski’s estate owed Medtronic $6 million to cover legal fees from the patent fight. Mirowski Family Ventures, which represents Mirowksi’s estate and controls several patents related to ICDs and cardiac resynchronization devices, has been fighting patent infringement cases against Medtronic, Guidant and successor Boston Scientific (NYSE:BSX) for several years.

The spat goes back to the 1970s, when Mirowski out-licensed the patents to Eli Lilly (NYSE:LLY). The patents eventually passed to Lilly subsidiary Guidant in 2004 and then on to Boston Scientific in 2006.

Five years later, a judge from the U.S. District Court for Delaware ruled in favor of Medtronic to invalidate one of the patents. After several rounds of appeals, the judge ordered MFV to cough up $6 million to cover Medtronic’s legal fees.

MFV appealed to the U.S. Court of Appeals for the Federal Circuit, asking the court to overturn the decision. MVF argued that if it was liable for the fees, Boston Scientific and Guidant should also be found liable.

But the Federal Circuit upheld the lower court’s ruling and this week’s decision by the Supreme Court marks another win for Medtronic in the years-long back-and-forth.

Filed Under: Cardiac Implants, Cardiovascular, Legal News, Wall Street Beat Tagged With: Boston Scientific, Eli Lilly & Co., Guidant Corp., Medtronic

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy